News & Events CTI Clinical Trial and Consulting Services Announces that Kathy Wekselman has joined as a Senior Research Scientist

Print Page

CTI Clinical Trial and Consulting Services Announces that Kathy Wekselman has joined as a Senior Research Scientist

August 20, 2012

CTI Clinical Trial and Consulting Services announces the hiring of Kathy Wekselman as a Senior Research Scientist

Kathy comes to CTI from INC Research, where she served as Director, Regulatory Strategy, Consulting, and Submissions. She was responsible for overseeing the preparation for IND, NDA, MAA and multiple other submissions. Prior to INC Research, Kathy held the position of Senior Director of Research Services at Camargo Pharmaceutical Services. In this role, Kathy managed a medical writing team and research group in drug development consulting. Her pharmaceutical career began at P&G Pharmaceuticals, where she spent nine years in various roles.

Kathy has also held various Adjunct Faculty Member positions at Northern Kentucky University, University of Cincinnati, Miami University, and Xavier University. Kathy earned a Bachelor’s of Arts in Art History from Oberlin College and Master’s of Librarianship from Emory University. She went on to complete a Bachelor’s of Science in Nursing and Doctorate in Nursing from the University of Cincinnati.

“Kathy brings a wealth of US and global regulatory experience expanding our current regulatory services,” according to Lynn Fallon, President of Consulting and Executive Vice President of CTI. “In addition, Kathy’s background and role as an educator will be a great benefit for both CTI Staff and our clients.”